GLP-1 and Microvascular Function in Type 2 Diabetes

NCT01740921 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide
OTHER: diet
DRUG: Aspirin

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Collaborators

[object Object]